1-5 of 5
Guangan He
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity

Available to Purchase
Bangxing Hong, Valerie Chapa, Uksha Saini, Puneet Modgil, David E. Cohn, Guangan He, Zahid H. Siddik, Anil K. Sood, Yuanqing Yan, Karuppaiyah Selvendiran, Guangsheng Pei, Zhongming Zhao, Ji Young Yoo, Balveen Kaur
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (2): 542–553.
https://doi.org/10.1158/1078-0432.CCR-20-2210
Published: 19 January 2021
View article titled, Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity
Open the PDF for Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity in another window
Includes: Supplementary data
Journal Articles

Abstract NT-109: VAL-083 (DIANHYDROGALACTITOL) SYNERGIZES WITH PARP INHIBITORS IN BRCA-PROFICIENT AND BRCA-DEFICIENT OVARIAN CANCER MODELS

Free
Anne Steino, Guangan He, Jeffrey Bacha, Dennis M. Brown, Zahid H. Siddik
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (22_Supplement): NT-109.
https://doi.org/10.1158/1557-3265.OVCASYMP18-NT-109
Published: 15 November 2019
View article titled, Abstract NT-109: VAL-083 (DIANHYDROGALACTITOL) SYNERGIZES WITH PARP INHIBITORS IN BRCA-PROFICIENT AND BRCA-DEFICIENT OVARIAN CANCER MODELS
Journal Articles

Abstract A01: Distinct mechanism of action of DNA-damaging agent dianhydrogalactitol (VAL-083) suggests combination therapy with PARP inhibitors

Free
Jeffrey A. Bacha, Guangan He, Xiaolei Xie, Anne Steino, Dennis M. Brown, Zahid H. Siddik
Journal: Clinical Cancer Research
Clin Cancer Res (2018) 24 (15_Supplement): A01.
https://doi.org/10.1158/1557-3265.OVCA17-A01
Published: 01 August 2018
View article titled, Abstract A01: Distinct mechanism of action of DNA-damaging agent dianhydrogalactitol (VAL-083) suggests combination therapy with PARP inhibitors
Journal Articles

Abstract A21: Tissue platinum concentration and tumor response in non-small cell lung cancer

Free
Eric S. Kim, Guangan He, Chi-Wan Chow, Junya Fujimoto, Jack J. Lee, Neda Kalhor, Stephen G. Swisher, Ignacio I. Wistuba, David J. Stewart, Zahid H. Siddik
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): A21.
https://doi.org/10.1158/1078-0432.12AACRIASLC-A21
Published: 01 February 2012
View article titled, Abstract A21: Tissue platinum concentration and tumor response in non-small cell lung cancer
Open the PDF for Abstract A21: Tissue platinum concentration and tumor response in non-small cell lung cancer in another window
Journal Articles

Bimodal Effects of 1R,2R -Diaminocyclohexane( trans -diacetato)(dichloro)platinum(IV) on Cell Cycle Checkpoints

Free
Jian Kuang, Guangan He, Zaifeng Huang, Abdul R. Khokhar, Zahid H. Siddik
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (11): 3629–3639.
Published: 01 November 2001
View article titled, Bimodal Effects of 1R,2R -Diaminocyclohexane( trans -diacetato)(dichloro)platinum(IV) on Cell Cycle Checkpoints
Open the PDF for Bimodal Effects of 1R,2R -Diaminocyclohexane( trans -diacetato)(dichloro)platinum(IV) on Cell Cycle Checkpoints in another window